Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05259839
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
AbbVie 283
Testing effectiveness (Phase 2)Active Not RecruitingNCT05123131
What this trial is testing

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cancer Trials Ireland 54
Large-scale testing (Phase 3)Looking for participantsNCT06679101
What this trial is testing

Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma
GlaxoSmithKline 520
Testing effectiveness (Phase 2)UnknownNCT03188172
What this trial is testing

MUK Nine b: OPTIMUM Treatment Protocol

Who this might be right for
Multiple Myeloma
University of Leeds 95
Testing effectiveness (Phase 2)UnknownNCT03809780
What this trial is testing

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
Kosin University Gospel Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT06520176
What this trial is testing

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University 99
Testing effectiveness (Phase 2)Looking for participantsNCT06910124
What this trial is testing

Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse

Who this might be right for
Multiple Myeloma
Dickran Kazandjian, MD 32
Early research (Phase 1)WithdrawnNCT04579523
What this trial is testing

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT05541978
What this trial is testing

Thrombosis in Patients With Multiple Myeloma in an University Medical Center

Who this might be right for
Multiple MyelomaVenous ThromboembolismArterial Thromboembolism
Catalina Codreanu 140
Testing effectiveness (Phase 2)Study completedNCT01255514
What this trial is testing

Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Yonsei University 30
Not applicableLooking for participantsNCT06149910
What this trial is testing

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma Without Mention of Remission
All4Cure 450
Large-scale testing (Phase 3)Study completedNCT01093196
What this trial is testing

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 660
Testing effectiveness (Phase 2)Active Not RecruitingNCT02420860
What this trial is testing

Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT01531998
What this trial is testing

Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT00349115
What this trial is testing

TCD Followed by autoSCT for Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 43
Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Testing effectiveness (Phase 2)UnknownNCT05712083
What this trial is testing

BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Zhejiang University 40
Large-scale testing (Phase 3)Study completedNCT00083551
What this trial is testing

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Who this might be right for
Multiple Myeloma
University of Arkansas 668
Testing effectiveness (Phase 2)Active Not RecruitingNCT04268498
What this trial is testing

Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Miami 310
Not applicableActive Not RecruitingNCT07026799
What this trial is testing

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Who this might be right for
Multiple Myeloma Bone Lesions
University Hospital Heidelberg 50
Next Page